Skip to main content

Andrew Neil Macintyre

Associate Professor in Medicine
Medicine, Duke Human Vaccine Institute

Selected Grants


Promoting T cell recovery after radiation injury with long-acting interleukin 7

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2027

Cytokine monitoring for Macrogenics trial CP-MGD020-01, Parts 1A, 1B, 2

ResearchPrincipal Investigator · Awarded by MacroGenics, Inc. · 2022 - 2024

EQAPOL OPTION 6 (YEAR 7)

ResearchInvestigator · Awarded by National Institutes of Health · 2017 - 2024

CIVICS Component A - Option 4

ResearchInvestigator · Awarded by National Institutes of Health · 2019 - 2024

Promoting T cell recovery after radiation injury with long-acting interleukin 7

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2027

Cytokine monitoring for Macrogenics trial CP-MGD020-01, Parts 1A, 1B, 2

ResearchPrincipal Investigator · Awarded by MacroGenics, Inc. · 2022 - 2024

EQAPOL OPTION 6 (YEAR 7)

ResearchInvestigator · Awarded by National Institutes of Health · 2017 - 2024

CIVICS Component A - Option 4

ResearchInvestigator · Awarded by National Institutes of Health · 2019 - 2024

CIVICs A Opt 12D Development of a multiplex HA binding assay to evaluate the breadth of vaccine-induced HA binding antibodies for CIVIC

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2024

Adjuvant Comparison for Peanut Allergy Immunotherapy

ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2024

Human Thymus Core (Core C)

ResearchManager · Awarded by The University of Texas MD Anderson Cancer Center · 2020 - 2024

Radiation Survival Cohort - Immune Monitoring Core

ResearchPrincipal Investigator · Awarded by Wake Forest University Health Sciences · 2020 - 2024

Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis

ResearchPrincipal Investigator · Awarded by University of Maryland, Baltimore · 2022 - 2024

SRA with Locus Biosciences

ResearchPrincipal Investigator · Awarded by Locus Biosciences, Inc. · 2023 - 2024

Gonorrhea Vaccine Cooperative Research Center (GV-CRC); Core C: Host Response Monitoring

ResearchPrincipal Investigator · Awarded by Henry M. Jackson Foundation · 2019 - 2024

Proteomics-Driven Reverse Vaccinology for Gonorrhea

ResearchPrincipal Investigator · Awarded by Oregon State University · 2022 - 2024

Long-term effects of total body irradiation on measles-induced immunological memory

ResearchPrincipal Investigator · Awarded by Columbia University · 2022 - 2023

Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2021 - 2023

VTEU Task D Option 1 Protocol FY.2015.A4D14.0033

ResearchInvestigator · Awarded by National Institutes of Health · 2015 - 2022

Experimental Human Infection with Isogenic Mutants of Neisseria gonorrhoeae

ResearchLaboratory Manager · Awarded by University of North Carolina - Chapel Hill · 2015 - 2022

Cytokine monitoring for Macrogenics trial CP-MGD014-01, Part 2

ResearchPrincipal Investigator · Awarded by MacroGenics, Inc. · 2021 - 2021

METHODS TO TEST LIFESTYLE, VAGINAL MICROENVIRONMENT, AND GENITOURINARY SYMPTOMS ACROSS MENOPAUSE TRANSITION

ResearchPrincipal Investigator · Awarded by University of Maryland · 2020 - 2021

Macrogenics Cytokine Profiling Subcontract

ResearchPrincipal Investigator · Awarded by MacroGenics, Inc. · 2018 - 2020

Core C: Monitoring Host Response

ResearchSenior Research Associate · Awarded by Henry M. Jackson Foundation · 2014 - 2020

Novel nanoparticle platform for antiviral vaccine and therapeutics

ResearchLaboratory Manager · Awarded by University of North Carolina - Chapel Hill · 2014 - 2020

Biomarker analysis of vaginal lavage samples

ResearchPrincipal Investigator · Awarded by University of Maryland, Baltimore · 2019 - 2019

Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory

ResearchPostdoctoral Associate · Awarded by National Institutes of Health · 2015 - 2015

Metabolic Control of T Cell Subsets and Pyruvate Dehydrogenase Kinase as a Target in Inflammatory Bowel Disease

ResearchPostdoc Scholar · Awarded by Kenneth Rainin Foundation · 2013 - 2014

External Relationships


  • Enzyvant Therapeutics
  • Oregon State University

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.